Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)
Clinical trial NCT01502956 · COMPLETED
Trial details
- NCT number
- NCT01502956
- Sponsor
- NICHD Pelvic Floor Disorders Network
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2016-07-01
- Enrollment
- 386
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.